PERNIX THERAPEUTICS HOLDINGS, INC.
Healthcare · Pharmaceutical Preparations · MD · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | |
|---|---|---|---|---|---|---|
| Revenue | $29.7M | $32.5M | $33.9M | $19.1M | $22.1M | $61.3M |
| Operating income | −$20.1M | −$23.8M | −$18.9M | −$14.1M | −$8.1M | −$1.7M |
| Net income | −$29.5M | −$25.9M | −$23.7M | −$9.5M | −$7.9M | −$1.4M |
| Total assets | $205.5M | $310.4M | $499.2M | $487.4M | $211.4M | $251.4M |
| Total liabilities | $379.7M | $424.5M | $466.1M | $403.8M | $100.7M | $138.6M |
| Equity | −$174.3M | −$114.1M | $33.1M | $83.6M | $110.7M | $78.5M |
| EPS (diluted) | $-2.94 | $-4.24 | $-6.16 | $-0.26 | $-0.23 | $-0.05 |
| Shares out. | 10.0M | 61.1M | 38.4M | 37.4M | 37.7M | 26.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2017- Operating margin
- −67.6%
- Net margin
- −99.1%
- Return on equity
- 16.9%
- Return on assets
- −14.3%
- Return on capital (ROCE)
- −18.0%
- Liabilities / assets
- 184.8%
- Debt / equity
- —
- Book value / share
- $-17.40
- Revenue growth (YoY)
- −8.4%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2017- Altman Z″ (distress)
- -8.05distress
- Accruals / assets
- −11.4%clean
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 5 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 14, 2007
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2006
- NT 10-Kmissed a reporting deadline ↗Apr 3, 2006
- NT 10-Qmissed a reporting deadline ↗Nov 16, 2004
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2001
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Bankruptcy or receivership · Regulation FD disclosureJun 26, 2019
- Director / officer change · Other material eventMay 21, 2019
- Director / officer changeMay 14, 2019
- Regulation FD disclosureMay 7, 2019
- Completed an acquisition or dispositionMay 6, 2019
- Entered a material agreementApr 19, 2019
- Delisting / listing-standard noticeApr 1, 2019
- Entered a material agreement · New financial obligation · Delisting / listing-standard noticeFeb 27, 2019
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12BSep 25, 2019
- 8-KFORM 8-KJun 26, 2019
- 8-KFORM 8-KMay 21, 2019
- 8-KFORM 8-KMay 14, 2019
- 8-KFORM 8-KMay 7, 2019
- 8-KFORM 8-KMay 6, 2019
- 8-KFORM 8-KApr 19, 2019
- 25-NSEApr 2, 2019
- 8-KApr 1, 2019
- 8-KFORM 8-KFeb 27, 2019
- 8-KFORM 8-KFeb 19, 2019
- SC 13G/AFeb 13, 2019
- SC 13G/AJan 10, 2019
- 4PRIMARY DOCUMENTJan 8, 2019
- CT ORDERDec 6, 2018
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.